Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVO | LLY | JNJ | ||
| Company | Novo Nordisk A/S ADR | Eli Lilly and Company | Johnson & Johnson | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 103.91 | 757.05 | 155.90 | ||
| High | 106.24 | 761.28 | 157.12 | ||
| Low | 103.86 | 745.08 | 154.11 | ||
| Last | 105.06 | 748.01 | 155.17 | ||
| Change | +2.43 | -1.91 | -0.33 | ||
| % Change | +2.37% | -0.25% | -0.21% | ||
| Volume | 6,143,300 | 4,015,400 | 8,265,900 | ||
| 20-Day Average Volume | 6,818,175 | 5,623,750 | 7,503,385 | ||
| Previous Close | 102.63 | 749.92 | 155.50 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 107.35 | 800.80 | 156.37 | ||
| 20-Day Raw Stochastic | 39.33% | 18.62% | 38.65% | ||
| 20-Day Relative Strength | 39.62% | 33.58% | 43.01% | ||
| Weighted Alpha | -11.16 | +10.28 | +0.57 | ||
| Today's Opinion | 100% Sell | 56% Sell | 24% Sell | ||
| Previous Opinion | 100% Sell | 56% Sell | 24% Sell | ||
| Last Month's Opinion | 88% Sell | 24% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.26% since 11/15/24 | +0.24% since 11/15/24 | +0.76% since 11/15/24 | ||
| Low | 99.42 on 11/18/24 | 711.40 on 11/18/24 | 151.81 on 11/20/24 | ||
| High | 106.24 on 11/22/24 | 761.28 on 11/22/24 | 157.12 on 11/22/24 | ||
| 1-Month | |||||
| %Chg | -9.80% since 10/22/24 | -17.72% since 10/22/24 | -5.07% since 10/22/24 | ||
| Low | 99.42 on 11/18/24 | 711.40 on 11/18/24 | 150.76 on 11/14/24 | ||
| High | 116.43 on 10/23/24 | 907.98 on 10/29/24 | 166.00 on 10/23/24 | ||
| 3-Month | |||||
| %Chg | -23.25% since 08/22/24 | -21.61% since 08/22/24 | -4.42% since 08/22/24 | ||
| Low | 99.42 on 11/18/24 | 711.40 on 11/18/24 | 150.76 on 11/14/24 | ||
| High | 139.74 on 08/30/24 | 972.48 on 08/27/24 | 168.85 on 09/04/24 | ||
| 6-Month | |||||
| %Chg | -21.61% since 05/22/24 | -6.84% since 05/22/24 | +1.09% since 05/22/24 | ||
| Low | 99.42 on 11/18/24 | 711.40 on 11/18/24 | 143.71 on 05/29/24 | ||
| High | 148.15 on 06/25/24 | 972.53 on 08/22/24 | 168.85 on 09/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 471,460,128 | 710,097,856 | 373,590,880 | ||
| Shares Outstanding, K | 4,487,532 | 949,316 | 2,407,623 | ||
| Annual Sales | 33,724,300,000 | 34,124,100,000 | 85,159,000,000 | ||
| Annual Net Income | 12,150,770,000 | 5,240,400,000 | 35,153,000,000 | ||
| Last Quarter Sales | 10,511,240,000 | 11,439,100,000 | 22,471,000,000 | ||
| Last Quarter Net Income | 4,024,170,000 | 970,300,000 | 2,694,000,000 | ||
| 60-Month Beta | 0.42 | 0.43 | 0.53 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.90 on 11/06/24 | 1.18 on 10/30/24 | 2.42 on 10/15/24 | ||
| Latest Earnings Date | 11/06/24 | 10/30/24 | 10/15/24 | ||
| Most Recent Dividend | 0.362 on 08/16/24 | 1.300 on 11/15/24 | 1.240 on 11/26/24 | ||
| Next Ex-Dividends Date | 08/16/24 | 11/15/24 | 11/26/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 33.21 | 73.74 | 15.19 | ||